Skip to main content
SRES 251 113th Congress Senate Health Cancer Health promotion and preventive care Medical research Medical tests and diagnostic methods

A resolution expressing the sense of the Senate that the United States Preventive Services Task Force should reevaluate its recommendations against prostate-specific antigen-based screening for prostate cancer for men in all age groups in consultation with appropriate specialists.

Introduced: September 23, 2013 See on congress.gov
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 23, 2013
Referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S6684-6685)
Sep 23, 2013
Introduced in Senate
 Plain-English summary Congressional Research Service

Calls for the U.S. Preventive Services Task Force to: (1) reevaluate its recommendation against prostate-specific antigen-based screening for prostate cancer for men in all age groups, (2) seriously engage and consult with specialists as it reevaluates its recommendation, and (3) identify areas for additional research and evaluation of methods of treatment of, and screening procedures for, prostate cancer.

Expresses the sense of the Senate that: (1) prostate cancer screening decisions should be made by each individual patient and his physician, taking into account the patient's risk factors and desire for treatment; and (2) steps should be taken to raise awareness of, and increase public knowledge about, prostate cancer, the benefits of early detection, and the appropriateness of screening tests.

What's happening now September 23, 2013

Referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S6684-6685)

 Committees of jurisdiction 1